IJPTX Performance — Vy(r) JPMorgan Emerging Markets Equity Portfolio, Class S2
Data updated: 2026-08-21
IJPTX returned +31.85% year to date and +56.14% over one year to Jun 2026. Annualised returns are +23.35% over 3 years and +4.94% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $188, against $179 for the category, and to $156 over one year, against $141. Volatility over the past three years was 16.47% a year. In the 12 months to Jun 2026 the fund lost a net $86.3M, and assets reached $210.01M.
IJPTX Growth of $100
What $100 invested in Vy(r) JPMorgan Emerging Markets Equity Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | IJPTX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $156 | $141 |
| 3 years (Jul 2023 – Jun 2026) | $188 | $179 |
| 5 years (Jul 2021 – Jun 2026) | $127 | $144 |
| Since data start (Jul 2019 – Jun 2026) | $155 | $195 |
IJPTX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +31.85% |
| 1 year | +56.14% |
| 3 years (annualised) | +23.35% |
| 5 years (annualised) | +4.94% |
IJPTX Annual Returns
Calendar-year total returns of Vy(r) JPMorgan Emerging Markets Equity Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +31.85% |
| 2025 | +38.83% |
| 2024 | +1.78% |
| 2023 | +6.43% |
| 2022 | −26.23% |
| 2021 | −10.07% |
| 2020 | +17.88% |
| 2019 (Jul–Dec) | +0.08% |
IJPTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +10.2% | +3.7% | −9.0% | +15.0% | +8.1% | +1.9% | — | — | — | — | — | — |
| 2025 | +2.8% | 0.0% | +1.2% | +0.5% | +5.6% | +6.2% | +0.7% | +3.5% | +6.7% | +4.3% | −0.8% | +2.9% |
| 2024 | −4.9% | +4.4% | +2.6% | −1.6% | +1.3% | +2.9% | −0.8% | +1.3% | +4.3% | −3.8% | −2.5% | −0.9% |
| 2023 | +9.7% | −6.4% | +1.8% | −1.2% | −2.2% | +4.7% | +3.7% | −6.9% | −3.7% | −2.7% | +7.4% | +3.8% |
| 2022 | −4.9% | −7.5% | −4.7% | −7.1% | +1.0% | −5.0% | +1.2% | −1.4% | −11.2% | −2.7% | +17.6% | −2.5% |
| 2021 | +2.7% | −0.7% | −3.9% | +1.9% | +2.1% | +1.3% | −7.4% | +4.4% | −4.7% | +0.6% | −5.4% | −0.8% |
| 2020 | 0.0% | 0.0% | −0.2% | +0.1% | 0.0% | +0.1% | +0.1% | +0.1% | 0.0% | 0.0% | +8.7% | +8.3% |
| 2019 | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% |
IJPTX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 16.47%
- 3-year Sharpe ratio: 1.14 (vs 4.5% risk-free rate)
- Best month: +15.05% (Apr 2026)
- Worst month: −9.02% (Mar 2026)
IJPTX Fund Flows
Monthly money in and out of Vy(r) JPMorgan Emerging Markets Equity Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$86.3M
- 12-month gross sales (incl. reinvestments): $96.1M
- Sales ÷ redemptions: 0.53×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $4.6M | $2.1M | $2.5M |
| May 2026 | $3.0M | $1.3M | $1.7M |
| Apr 2026 | $1.1M | $2.3M | −$1.2M |
| Mar 2026 | $1.7M | $3.0M | −$1.3M |
| Feb 2026 | $3.9M | $1.5M | $2.4M |
| Jan 2026 | $6.9M | $3.0M | $4.0M |
| Dec 2025 | $1.3M | $10.6M | −$9.3M |
| Nov 2025 | $1.0M | $2.7M | −$1.7M |
| Oct 2025 | $2.7M | $1.6M | $1.1M |
| Sep 2025 | $64.1M | $145.5M | −$81.4M |
| Aug 2025 | $889K | $3.8M | −$2.9M |
| Jul 2025 | $4.8M | $5.0M | −$184K |
IJPTX Assets Under Management
Net assets of Vy(r) JPMorgan Emerging Markets Equity Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $210.01M |
| 2026-03-31 | $163.37M |
| 2025-12-31 | $152.31M |
| 2025-09-30 | $150.70M |
| 2025-06-30 | $274.64M |
| 2025-03-31 | $254.75M |
| 2024-12-31 | $258.04M |
| 2024-09-30 | $289.71M |
| 2024-06-30 | $287.94M |
| 2024-03-31 | $290.85M |
| 2023-12-31 | $295.76M |
| 2023-09-30 | $280.12M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.